Ankur Dhingra, SVP and Chief Financial Officer of Illumina Inc. ($ILMN), made one open market purchase of company shares in the last year, totaling nearly $500,000. His most recent buy occurred on May 12, 2025. This ranks him 886th among nearly 5,000 insiders in our database by purchase value, below the average of about $1.5 million across roughly 3.3 transactions per insider. Dhingra reported no open market sales during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 5, 2026 | ILLUMINA, INC. | $ILMN | Dhingra Ankur | SVP, Chief Financial Officer | A | Performance Shares | 10918 | $128.24 | 10,918.0000 | 201,000,000 | 9999.99% | 0.01% |
| March 5, 2026 | ILLUMINA, INC. | $ILMN | Dhingra Ankur | SVP, Chief Financial Officer | A | Common Stock | 9358 | $128.24 | 34,264.0000 | 201,000,000 | 37.57% | 0.00% |
| March 5, 2026 | ILLUMINA, INC. | $ILMN | Dhingra Ankur | SVP, Chief Financial Officer | A | Performance Shares | 10918 | $128.24 | 10,918.0000 | 201,000,000 | 9999.99% | 0.01% |
| May 12, 2025 | ILLUMINA, INC. | $ILMN | Dhingra Ankur | SVP, Chief Financial Officer | P | Common Stock | 6100 | $81.21 | 24,906.0000 | 201,000,000 | 32.44% | 0.00% |
| March 5, 2025 | ILLUMINA, INC. | $ILMN | Dhingra Ankur | SVP, Chief Financial Officer | A | Performance Shares | 11437 | $0.00 | 11,437.0000 | 200,000,000 | 9999.99% | 0.01% |
| March 5, 2025 | ILLUMINA, INC. | $ILMN | Dhingra Ankur | SVP, Chief Financial Officer | A | Performance Shares | 11437 | $0.00 | 11,437.0000 | 200,000,000 | 9999.99% | 0.01% |
| March 5, 2025 | ILLUMINA, INC. | $ILMN | Dhingra Ankur | SVP, Chief Financial Officer | A | Common Stock | 9803 | $0.00 | 18,806.0000 | 200,000,000 | 108.89% | 0.00% |
| May 6, 2024 | ILLUMINA, INC. | $ILMN | Dhingra Ankur | SVP, Chief Financial Officer | A | Performance Shares | 10296 | $0.00 | 10,296.0000 | 199,000,000 | 9999.99% | 0.01% |
| May 6, 2024 | ILLUMINA, INC. | $ILMN | Dhingra Ankur | SVP, Chief Financial Officer | A | Common Stock | 8826 | $0.00 | 8,826.0000 | 199,000,000 | 9999.99% | 0.00% |
| May 6, 2024 | ILLUMINA, INC. | $ILMN | Dhingra Ankur | SVP, Chief Financial Officer | A | Performance Shares | 10296 | $0.00 | 10,296.0000 | 199,000,000 | 9999.99% | 0.01% |
| March 26, 2024 | Summit Therapeutics Inc. | $SMMT | Dhingra Ankur | Chief Financial Officer | P | Common Stock | 100000 | $3.75 | 354,958.0000 | 0 | 39.22% | 0.00% |
| Dec. 13, 2023 | Summit Therapeutics Inc. | $SMMT | Dhingra Ankur | Chief Financial Officer | P | Common Stock | 700 | $2.15 | 235,258.0000 | 0 | 0.30% | 0.00% |
| Dec. 13, 2023 | Summit Therapeutics Inc. | $SMMT | Dhingra Ankur | Chief Financial Officer | P | Common Stock | 19700 | $2.17 | 254,958.0000 | 0 | 8.37% | 0.00% |
| Aug. 16, 2022 | Summit Therapeutics Inc. | $SMMT | Dhingra Ankur | Chief Financial Officer | P | Common Stock | 13027 | $0.97 | 77,723.0000 | 0 | 20.14% | 0.00% |
| March 7, 2023 | Summit Therapeutics Inc. | $SMMT | Dhingra Ankur | Chief Financial Officer | P | Common Stock | 196362 | $1.05 | 274,085.0000 | 0 | 252.64% | 0.00% |
| Aug. 16, 2022 | Summit Therapeutics Inc. | $SMMT | Dhingra Ankur | Chief Financial Officer | P | Common Stock | 24658 | $0.97 | 77,723.0000 | 0 | 46.47% | 0.00% |